See today's BioWorld
To read the full story, subscribe or sign in.

Generic firms agree to pay $450M to resolve price-fixing allegations

Oct. 4, 2021
By Mari Serebrov
Three generic drug companies have agreed to pay a total of nearly $450 million to resolve U.S. Department of Justice (DoJ) price-fixing allegations.
BioWorld Regulatory Generic U.S.